352 related articles for article (PubMed ID: 10933057)
41. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines.
Kamiyama T; Une Y; Uchino J; Hamada J
Int J Oncol; 1998 Mar; 12(3):655-9. PubMed ID: 9472107
[TBL] [Abstract][Full Text] [Related]
42. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
Chen K; Zhang S; Ji Y; Li J; An P; Ren H; Liang R; Yang J; Li Z
PLoS One; 2013; 8(9):e72927. PubMed ID: 24039823
[TBL] [Abstract][Full Text] [Related]
43. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
[TBL] [Abstract][Full Text] [Related]
44. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
45. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
46. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
47. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson EW
Clin Exp Metastasis; 1997 Mar; 15(2):111-20. PubMed ID: 9062387
[TBL] [Abstract][Full Text] [Related]
48. Down-Regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion.
Martinella-Catusse C; Polette M; Noel A; Gilles C; Dehan P; Munaut C; Colige A; Volders L; Monboisse JC; Foidart JM; Birembaut P
Lab Invest; 2001 Feb; 81(2):167-75. PubMed ID: 11232638
[TBL] [Abstract][Full Text] [Related]
49. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
Caenazzo C; Onisto M; Sartor L; Scalerta R; Giraldo A; Nitti D; Garbisa S
Clin Cancer Res; 1998 Sep; 4(9):2179-86. PubMed ID: 9748137
[TBL] [Abstract][Full Text] [Related]
50. Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
Harada T; Arii S; Mise M; Imamura T; Higashitsuji H; Furutani M; Niwano M; Ishigami S; Fukumoto M; Seiki M; Sato H; Imamura M
J Hepatol; 1998 Feb; 28(2):231-9. PubMed ID: 9514536
[TBL] [Abstract][Full Text] [Related]
51. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
[TBL] [Abstract][Full Text] [Related]
52. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
53. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
54. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
55. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
56. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.
Koli K; Keski-Oja J
Cell Growth Differ; 2000 Apr; 11(4):221-9. PubMed ID: 10775039
[TBL] [Abstract][Full Text] [Related]
57. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.
Maquoi E; Frankenne F; Baramova E; Munaut C; Sounni NE; Remacle A; Noël A; Murphy G; Foidart JM
J Biol Chem; 2000 Apr; 275(15):11368-78. PubMed ID: 10753951
[TBL] [Abstract][Full Text] [Related]
58. Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo.
Nonaka T; Nishibashi K; Itoh Y; Yana I; Seiki M
Mol Cancer Ther; 2005 Aug; 4(8):1157-66. PubMed ID: 16093431
[TBL] [Abstract][Full Text] [Related]
59. In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.
Paquette B; Baptiste C; Therriault H; Arguin G; Plouffe B; Lemay R
Br J Cancer; 2007 Dec; 97(11):1505-12. PubMed ID: 17987037
[TBL] [Abstract][Full Text] [Related]
60. Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line.
Harayama T; Ohuchi E; Aoki T; Sato H; Seiki M; Okada Y
Jpn J Cancer Res; 1999 Sep; 90(9):942-50. PubMed ID: 10551322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
